Nav: Home

Scripps Florida awarded $2.5 million to advance development of RNA-based therapeutics

May 04, 2016

JUPITER, FL May 4, 2016 - Scientists from the Florida campus of The Scripps Research Institute (TSRI) have been awarded a $2.5 million grant from the National Institute of General Medical Sciences of the National Institutes of Health to design precision drug candidates that target disease-associated RNAs.

Matthew Disney, a TSRI professor, will be the principal investigator for the new four-year study.

"A major goal of genome sequencing efforts is to develop drug targets that could enable the development of patient-specific therapies," Disney said. "In this project, we are developing quick ways to convert this information into lead drugs by using several novel and transformative technologies we developed. The new grant will keep us moving forward and allow us to tackle many new challenges in the area of precision medicine."

While to date large macromolecules have generally been used to target RNA, small molecules can pass through the blood-brain barrier, a critical factor in the treatment of neurological diseases and cancer that affects the brain.

The Disney lab's untraditional approach has been broadly applicable in developing precision probes to target disease-causing RNA repeat expansions, which cause more than 30 diseases--including Huntington's, which has no cure--affecting millions worldwide.

Disney's successful efforts in identifying various drug-like small molecules that bind to RNA is the result of his lab's broad, bottom-up, computational approach known as Inforna, which can deep mine information against such genome sequences and cellular RNAs.

The new grant will enable Disney and his team to further investigate the manipulation of microRNAs. Discovered only in the 1990s, microRNAs are short molecules that work within virtually all animal and plant cells. Typically, each one functions as a "dimmer switch" for one or more genes, binding to the transcripts of those genes and effectively keeping them from being translated into proteins.

The new grant will also allow Disney to expand development of small molecules that target two miRNAs with a single small molecule and to study the cellular consequences targeting multiple disease pathways using what he calls a "designer poly-pharmacy approach."

The number of the grant is 2R01GM097455-05.
-end-


Scripps Research Institute

Related Rna Articles:

How RNA formed at the origins of life
A single process for how a group of molecules called nucleotides were made on the early Earth, before life began, has been suggested by a UCL-led team of researchers.
RNA and longevity: Discovering the mechanisms behind aging
Korean researchers suggests that NMD-mediated RNA quality control is critical for longevity in the roundworm called C. elegans, a popularly used animal for aging research.
Don't kill the messenger RNA
Success of new protein-making therapy for hemophilia opens door for treating many other diseases.
RNA modification important for brain function
Researchers at the Institute of Molecular Biology (IMB) and Johannes Gutenberg University Mainz (JGU) have shown that a new way of regulating genes is vital for the activity of the nervous system.
Atlas of the RNA universe takes shape
In the last few years, small snippets of RNA, which may have played a key role in the planet's earliest flickering of life, have been uncovered and examined in great detail.
Punching cancer with RNA knuckles
Researchers achieved an unexpected eye-popping reduction of ovarian cancer during successful tests of targeted nanohydrogel delivery in vivo in mice.
Gatekeeping proteins to aberrant RNA: You shall not pass
Berkeley Lab researchers found that aberrant strands of genetic code have telltale signs that enable gateway proteins to recognize and block them from exiting the nucleus.
Short RNA molecules mapped in single cell
Researchers at Karolinska Institutet have measured the absolute numbers of short, non-coding, RNA sequences in individual embryonic stem cells.
Watching RNA fold
New technology takes a nucleotide-resolution snapshot of RNA as it is folding, which could lead to discoveries in biology, gene expression, and disease.
Bacteria: Third RNA binding protein identified
Pathogenic bacteria use small RNA molecules to adapt to their environment.

Related Rna Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Jumpstarting Creativity
Our greatest breakthroughs and triumphs have one thing in common: creativity. But how do you ignite it? And how do you rekindle it? This hour, TED speakers explore ideas on jumpstarting creativity. Guests include economist Tim Harford, producer Helen Marriage, artificial intelligence researcher Steve Engels, and behavioral scientist Marily Oppezzo.
Now Playing: Science for the People

#524 The Human Network
What does a network of humans look like and how does it work? How does information spread? How do decisions and opinions spread? What gets distorted as it moves through the network and why? This week we dig into the ins and outs of human networks with Matthew Jackson, Professor of Economics at Stanford University and author of the book "The Human Network: How Your Social Position Determines Your Power, Beliefs, and Behaviours".